beauvericin has been researched along with Lung Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, BF; Jow, GM; Lin, HI; Lu, CL | 1 |
Chen, BF; Chou, CJ; Jow, GM; Lee, YJ; Lin, HI; Lu, JL; Tsai, MC | 1 |
2 other study(ies) available for beauvericin and Lung Neoplasms
Article | Year |
---|---|
Beauvericin-induced cell apoptosis through the mitogen-activated protein kinase pathway in human nonsmall cell lung cancer A549 cells.
Topics: A549 Cells; Antineoplastic Agents; Apoptosis; Butadienes; Carcinoma, Non-Small-Cell Lung; Cell Survival; Depsipeptides; Dose-Response Relationship, Drug; G1 Phase Cell Cycle Checkpoints; Lung Neoplasms; Mitogen-Activated Protein Kinases; Nitriles; Protein Kinase Inhibitors; Signal Transduction | 2016 |
Involvement of Bcl-2 family, cytochrome c and caspase 3 in induction of apoptosis by beauvericin in human non-small cell lung cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Non-Small-Cell Lung; Caspase 3; Caspases; Cell Line, Tumor; Cell Survival; Cytochromes c; Depsipeptides; DNA Fragmentation; Humans; In Situ Nick-End Labeling; Lung Neoplasms; Membrane Potentials; Mitochondria; Proto-Oncogene Proteins c-bcl-2 | 2005 |